Current treatments involve targeting and killing specific cancer cells, but new research points to the efficacy of an ecological approach to curing the disease.
A study confirms that people who make less than $50,000 a year are 37 percent less likely to participate in clinical trials for new cancer treatments—and that's bad news for everybody involved.
Biologists have been working for decades on cancer research—and they’re making progress. But to really stand a chance against this aggressive disease, we should focus on more interdisciplinary collaboration.